Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Assets Average (2016 - 2025)

Historic Assets Average for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to $501.7 million.

  • CorMedix's Assets Average rose 64156.4% to $501.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $501.7 million, marking a year-over-year increase of 64156.4%. This contributed to the annual value of $65.5 million for FY2022, which is 1076.49% up from last year.
  • As of Q3 2025, CorMedix's Assets Average stood at $501.7 million, which was up 64156.4% from $201.1 million recorded in Q2 2025.
  • CorMedix's 5-year Assets Average high stood at $501.7 million for Q3 2025, and its period low was $58.1 million during Q2 2023.
  • For the 5-year period, CorMedix's Assets Average averaged around $105.5 million, with its median value being $69.9 million (2021).
  • In the last 5 years, CorMedix's Assets Average tumbled by 1964.36% in 2022 and then skyrocketed by 64156.4% in 2025.
  • CorMedix's Assets Average (Quarter) stood at $72.2 million in 2021, then dropped by 14.01% to $62.1 million in 2022, then rose by 19.62% to $74.2 million in 2023, then soared by 32.31% to $98.2 million in 2024, then surged by 410.84% to $501.7 million in 2025.
  • Its last three reported values are $501.7 million in Q3 2025, $201.1 million for Q2 2025, and $134.2 million during Q1 2025.